Vol 4, No 8 (April 2016): Annals of Translational Medicine (Lung Cancer Screening)


Lung cancer screening moving forward
Witold Rzyman, James L. Mulshine

Review Article

Lung cancer epidemiology: contemporary and future challenges worldwide
Joanna Didkowska, Urszula Wojciechowska, Marta Mańczuk, Jakub Łobaszewski
Risk factors assessment and risk prediction models in lung cancer screening candidates
Mariusz Adamek, Ewa Wachuła, Sylwia Szabłowska-Siwik, Agnieszka Boratyn-Nowicka, Damian Czyżewski
Implementation and organization of lung cancer screening
Jesper Holst Pedersen, Haseem Ashraf
The importance of the regimen of screening in maximizing the benefit and minimizing the harms
Claudia I. Henschke, Kunwei Li, Rowena Yip, Mary Salvatore, David F. Yankelevitz
Advancing and sharing the knowledge base of CT screening for lung cancer
David F. Yankelevitz, Claudia I. Henschke
2016 reflections on the favorable cost-benefit of lung cancer screening
Bruce Pyenson, Gabriela Dieguez
Management of CT screen-detected lung nodule: the thoracic surgeon perspective
Adnan M. Al-Ayoubi, Raja M. Flores
Smoking cessation and lung cancer screening
Jesper Holst Pedersen, Philip Tønnesen, Haseem Ashraf
Biomarkers of risk to develop lung cancer in the new screening era
Thomas Atwater, Pierre P. Massion
Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT?
Joseph Shemesh
Lung cancer screening in patients with chronic obstructive pulmonary disease
Jessica Gonzalez, Marta Marín, Pablo Sánchez-Salcedo, Javier J. Zulueta


The focused issue“Lung Cancer Screening” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Witold Rzyman and James L. Mulshine served as the unpaid Guest Editors for the focused issue.